32 05FPRF Immune Design C orp. IMDZ -04-1702 SAP Draft V1.0 for Protocol V2.0 Version Date: 2018- 05-25 Confidential 5 / 36 8.3 Safety Analyses .............................................................................................................. 32 8.3.1 Adverse Events .......................................................................................................